About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Find trials: by AGENT | by TYPE of LYMPHOMA AND treatment status | of INTEREST

   Search Site | Ask Question | Sign Guest book |  How to Help!

Patients Against Lymphoma

 

Clinical Trials > Find based on Other Criteria

Last update: 10/07/2013 

by Age | Cachexia (weight loss) | Complementary and Alternative | Fatigue
First line
| by Grade |
by Phase | By Stage
Quality of Life
by Stage | Refractory

or select from menu:

Click here to request a trial search

 by Age

Click here for meaning of Phase I, II, III studies.
Return to top

Investigational therapies for lymphomas:
bullet
Children all phases - Phase I | Phase II | Phase III
bullet
Elderly - all phases - Phase I | Phase II | Phase III

for Cachexia 
(cancer-associated weight loss)

Return to top


Investigational therapies for :
bullet
Cachexia

 

Complementary &
Alternative Medicine (CAM)

The objective of responsible CAM practices are generally to improve quality of life, general health or performance - or to mitigate the side effects of therapy. 

It is unethical to prescribe CAM practices as therapy for lymphoma or other cancers outside of a clinical trial.

Return to top


Investigational therapies for lymphomas:
bullet
CAM studies for lymphoma 
bullet
Quality of Life (QOL)

 

Fatigue studies

Return to top


bullet
For treatment or lymphoma-related fatigue

First-line for
previously untreated

"First line" means that participants must have had no prior treatment (or significant treatment), not that the therapy is superior.

Return to top

 


Investigational therapies for previously untreated lymphomas:

Note: This criteria (untreated) is challenging to filter for by query command. Please confirm that the protocols listed are truly for untreated lymphoma by reading the eligibility sections.

bullet
Trials by subtype and treatment status PDF / Web

Treatment-specific first-line studies:

bullet
Chemotherapy, but not doxorubicin (component of CHOP)
bullet
Excluding chemotherapy or transplants
bullet
Antibodies - excluding chemotherapy or transplants
bullet
Vaccines 

by Grade of Lymphoma

Grade refers to how aggressive or indolent (slow growing)  the lymphoma is. Grade I is generally most  indolent, and Grade III is most aggressive.
Return to top

 


Investigational therapies for lymphomas by rate of growth:

bullet
Grade I | Grade II  | Grade III 
bullet
Indolent lymphomas
bullet
Untreated indolent lymphoma
bullet
Indolent recurrent lymphomas 
bullet
Transformed lymphoma (indolent changed to aggressive)
bullet
Aggressive lymphomas
bullet
Aggressive recurrent lymphoma

by Phase of Study

Click here for meaning
of Phase I, II, III studies.
Return to top

 


Investigational therapies for lymphomas or CLL:

bullet
All studies and phases
bullet
Phase I trials (new)| Phase II | Phase III  | Phase IV
bullet
Expanded Access (See for background on compassionate use)

 

Quality of Life studies

Return to top


Investigational therapies for:

bullet
Quality of Life (QOL)

by Stage 

Stage refers to how widespread the disease is.
Return to top

Investigational therapies for lymphomas:

bullet
All therapies for all stages -
Stage I | Stage II | Stage III | Stage IV
bullet
Radiotherapy
Stage I
| Stage II | Stage III | Stage IV

studies for Refractory
Lymphomas

Refractory refers to disease that is resistant to standard treatments.

It is a term without precise definition, however ... in that refractory to therapy A does not mean the lymphoma is not sensitive to therapy B, for example.

 
Return to top

 


Studies for refractory (treatment resistant) lymphomas: 

bullet
See also Pipeline for single agents
bullet
Trials by subtype and treatment status PDF / Web
bullet
All Lymphoma  
 
NHL-indolent | NHL - aggressive | Hodgkins | T-cell 

Treatment-specific studies for refractory lymphomas: 

bullet
Immunotherapy

Stem Cell Transplants (SCT):

bullet
Autologous (stem cells from self) 
All lymphomas | CLL/SLL | NHL | Hodgkin's | T-cell
bullet
Allogeneic (stem cells from donor) 
All lymphomas | NHL | Hodgkin's | T-cell
bullet
Mini-transplants (stem cells from donor) 
 All lymphomas | NHL | Hodgkin's | T-cell 
(non-myeloablative transplant)
bullet
Refractory AND NOT SCT 
All lymphomas | NHL | Hodgkin's | T-cell
 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright 2004,  All Rights Reserved.